September 20, 2023
2 mins read

Musk’s Neuralink to start human trial of brain implant

The study will evaluate the safety and functionality of the technology, according to a statement…reports Asian Lite News

Elon Musk’s brain-implant startup, Neuralink, said it has received approval from an independent review board to begin recruiting patients for its first human trial. The company is seeking people with paralysis to test its experimental device in a six-year study.

Neuralink is one of several companies developing a brain-computer interface (BCI) that can collect and analyze brain signals. But its billionaire executive’s bombastic promotion of the company, including promises to develop an all-encompassing brain computer to help humans keep up with artificial intelligence, has attracted skepticism and raised ethical concerns among neuroscientists and other experts.

Last year, the Food and Drug Administration denied the company’s request to fast-track human trials, but in May approved Neuralink for an investigational device exemption (IDE) that allows a device to be used for clinical studies. The agency has not disclosed how its initial concerns were resolved.

Neuralink says it is looking for patients with quadriplegia due to vertical spinal cord injury or ALS. Participants will have a BCI surgically implanted using a proprietary robot in a region of the brain that controls movement, with the goal of enabling them to control a computer cursor or a keyboard using just their thoughts. The study will evaluate the safety and functionality of the technology, according to a statement.

The company’s announcement comes months after it received regulatory approval for a trial. Its previous testing in animals is under scrutiny, after reports that trials caused unnecessary suffering. Former employees characterized tests as “hack jobs”, telling Reuters that in one instance, the device was implanted in the wrong position in pigs, leading to their euthanasia.

The allegations triggered several investigations, including inquiry from the Department of Agriculture into animal abuse and the Department of Transportation over mishandling of biohazardous materials across state lines.

The company did not respond immediately to queries about when and where the trial will be conducted, or how many participants it will involve. If its device proves safe for human use, it could still take decades before it is cleared for patients outside the trial.

ALSO READ-Musk, Netanyahu hold discussion on AI

Previous Story

UK Presses On with Trade Talks with India Despite Trudeau’s Accusations

Next Story

Google integrates Bard chatbot with its apps

Latest from -Top News

Multi-alignment, upgraded

With US ties strained and China tense, New Delhi taps Europe’s harder edge for co-development, clean tech and strategic autonomy, writes Manoj Menon India is recalibrating its great-power hedging as frictions with

India-EU Trade Deal Breakthrough Soon?

Negotiators report increased momentum in discussions, which have been given a boost from US President Donald Trump’s tariff offensive…reports Asian Lite News India and the European Union aim to finalise a trade

Europe Seeks Peace in Gaza

European countries condemn Israeli interception of Gaza-bound flotilla, demand safety of citizens…reports Asian Lite News Israel’s interception of an international flotilla carrying humanitarian aid to Gaza has sparked condemnation across Europe, with

GAZA: Egypt to Host Peace Talks

Egypt hopes the discussions will help “end the war and the suffering of the brotherly Palestinian people, which has continued for two consecutive years…reports Asian Lite News Egypt will host Israeli and

‘My Injuries Made Me’

During his four-year battle with injury, the incumbent fast bowling spearhead made occasional appearances but couldn’t bear the workload and demands of red-ball cricket….reports Asian Lite News England tearaway Jofra Archer believes
Go toTop

Don't Miss

Twitter Blue with verification arrives

Subscribers will be able to change their handle, display name

Musk vouches to ‘fight for max freedom of speech’ on X

The article also claims that this is in contrast to